JPY 3190.0
(1.11%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 28.6 Billion JPY | 2.73% |
2022 | 27.84 Billion JPY | 10.15% |
2021 | 25.27 Billion JPY | 5.35% |
2020 | 23.99 Billion JPY | 7.26% |
2019 | 22.37 Billion JPY | 9.81% |
2018 | 20.37 Billion JPY | 14.65% |
2017 | 17.76 Billion JPY | 14.08% |
2016 | 15.57 Billion JPY | 15.05% |
2015 | 13.53 Billion JPY | 21.61% |
2014 | 11.13 Billion JPY | 9.08% |
2013 | 10.2 Billion JPY | 3.15% |
2012 | 9.89 Billion JPY | -1.9% |
2011 | 10.08 Billion JPY | 7.53% |
2010 | 9.37 Billion JPY | 20.23% |
2009 | 7.8 Billion JPY | 11.07% |
2008 | 7.02 Billion JPY | 20.68% |
2007 | 5.81 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 7.83 Billion JPY | 4.93% |
2023 Q3 | 6.74 Billion JPY | -4.47% |
2023 FY | 28.6 Billion JPY | 2.73% |
2023 Q2 | 7.06 Billion JPY | -3.64% |
2023 Q1 | 7.33 Billion JPY | 0.98% |
2023 Q4 | 7.46 Billion JPY | 10.58% |
2022 Q2 | 6.76 Billion JPY | -3.29% |
2022 Q3 | 6.82 Billion JPY | 0.78% |
2022 Q4 | 7.26 Billion JPY | 6.45% |
2022 Q1 | 6.99 Billion JPY | 2.13% |
2022 FY | 27.84 Billion JPY | 10.15% |
2021 Q3 | 6.16 Billion JPY | 1.84% |
2021 FY | 25.27 Billion JPY | 5.35% |
2021 Q1 | 6.2 Billion JPY | -5.87% |
2021 Q2 | 6.05 Billion JPY | -2.46% |
2021 Q4 | 6.85 Billion JPY | 11.11% |
2020 Q4 | 6.59 Billion JPY | 14.8% |
2020 Q3 | 5.74 Billion JPY | -0.9% |
2020 Q2 | 5.79 Billion JPY | -1.06% |
2020 Q1 | 5.85 Billion JPY | -3.09% |
2020 FY | 23.99 Billion JPY | 7.26% |
2019 Q2 | 5.47 Billion JPY | 0.16% |
2019 Q4 | 6.04 Billion JPY | 12.36% |
2019 FY | 22.37 Billion JPY | 9.81% |
2019 Q1 | 5.46 Billion JPY | 0.29% |
2019 Q3 | 5.38 Billion JPY | -1.75% |
2018 Q3 | 4.99 Billion JPY | -0.02% |
2018 Q4 | 5.45 Billion JPY | 9.26% |
2018 FY | 20.37 Billion JPY | 14.65% |
2018 Q1 | 4.93 Billion JPY | 4.82% |
2018 Q2 | 4.99 Billion JPY | 1.07% |
2017 Q1 | 4.28 Billion JPY | 2.55% |
2017 Q4 | 4.71 Billion JPY | 6.87% |
2017 Q3 | 4.4 Billion JPY | 0.94% |
2017 FY | 17.76 Billion JPY | 14.08% |
2017 Q2 | 4.36 Billion JPY | 2.0% |
2016 Q4 | 4.17 Billion JPY | 8.27% |
2016 Q1 | 3.75 Billion JPY | 1.66% |
2016 Q2 | 3.79 Billion JPY | 1.03% |
2016 Q3 | 3.85 Billion JPY | 1.71% |
2016 FY | 15.57 Billion JPY | 15.05% |
2015 FY | 13.53 Billion JPY | 21.61% |
2015 Q4 | 3.69 Billion JPY | 9.32% |
2015 Q3 | 3.37 Billion JPY | 4.3% |
2015 Q2 | 3.23 Billion JPY | 0.2% |
2015 Q1 | 3.23 Billion JPY | 6.52% |
2014 Q4 | 3.03 Billion JPY | 12.85% |
2014 FY | 11.13 Billion JPY | 9.08% |
2014 Q1 | 2.7 Billion JPY | 1.73% |
2014 Q2 | 2.7 Billion JPY | 0.19% |
2014 Q3 | 2.68 Billion JPY | -0.71% |
2013 FY | 10.2 Billion JPY | 3.15% |
2013 Q2 | 2.54 Billion JPY | 4.05% |
2013 Q3 | 2.55 Billion JPY | 0.61% |
2013 Q4 | 2.65 Billion JPY | 3.8% |
2013 Q1 | 2.44 Billion JPY | 2.23% |
2012 FY | 9.89 Billion JPY | -1.9% |
2012 Q2 | 2.5 Billion JPY | -8.78% |
2012 Q4 | 2.39 Billion JPY | 6.41% |
2012 Q1 | 2.74 Billion JPY | 5.72% |
2012 Q3 | 2.24 Billion JPY | -10.32% |
2011 Q4 | 2.59 Billion JPY | 3.32% |
2011 Q3 | 2.51 Billion JPY | -0.09% |
2011 Q2 | 2.51 Billion JPY | 2.68% |
2011 Q1 | 2.45 Billion JPY | -5.06% |
2011 FY | 10.08 Billion JPY | 7.53% |
2010 Q2 | 2.39 Billion JPY | 10.12% |
2010 Q3 | 2.23 Billion JPY | -6.77% |
2010 FY | 9.37 Billion JPY | 20.23% |
2010 Q1 | 2.17 Billion JPY | 4.3% |
2010 Q4 | 2.58 Billion JPY | 15.79% |
2009 Q2 | 1.88 Billion JPY | 0.54% |
2009 FY | 7.8 Billion JPY | 11.07% |
2009 Q4 | 2.08 Billion JPY | 6.25% |
2009 Q1 | 1.87 Billion JPY | -2.35% |
2009 Q3 | 1.96 Billion JPY | 4.09% |
2008 Q3 | 1.72 Billion JPY | 4.18% |
2008 Q2 | 1.65 Billion JPY | -3.33% |
2008 Q1 | 1.71 Billion JPY | 0.0% |
2008 FY | 7.02 Billion JPY | 20.68% |
2008 Q4 | 1.91 Billion JPY | 10.97% |
2007 FY | 5.81 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
HEARTSEED INC | 1.8 Billion JPY | -1485.401% |
Cawachi Limited | 58.2 Billion JPY | 50.85% |
Pharmarise Holdings Corporation | 7.53 Billion JPY | -279.742% |
Qol Holdings Co., Ltd. | 14.92 Billion JPY | -91.652% |
MatsukiyoCocokara & Co. | 278.39 Billion JPY | 89.725% |
Welcia Holdings Co., Ltd. | 326.87 Billion JPY | 91.249% |
Create SD Holdings Co., Ltd. | 85.11 Billion JPY | 66.391% |
NIHON CHOUZAI Co.,Ltd. | 48.09 Billion JPY | 40.519% |
COSMOS Pharmaceutical Corporation | 156.8 Billion JPY | 81.757% |
Tsuruha Holdings Inc. | 263.07 Billion JPY | 89.126% |
Ohki Healthcare Holdings Co.,Ltd. | 14.84 Billion JPY | -92.672% |
Satudora Holdings Co.,Ltd. | 20.92 Billion JPY | -36.707% |
Kusuri No Aoki Holdings Co., Ltd. | 99.52 Billion JPY | 71.257% |
Medical System Network Co., Ltd. | 44.09 Billion JPY | 35.125% |
Shinnihonseiyaku Co., Ltd. | 26.55 Billion JPY | -7.711% |
Sugi Holdings Co.,Ltd. | 192.21 Billion JPY | 85.118% |
YAKUODO HOLDINGS Co., Ltd. | 22.65 Billion JPY | -26.296% |
Astena Holdings Co., Ltd. | 14.04 Billion JPY | -103.691% |
Ain Holdings Inc. | 39.09 Billion JPY | 26.822% |
Sundrug Co.,Ltd. | 148.32 Billion JPY | 80.714% |